semaglutide intestinal blockage Wegovy Lawsuits FDA Ileus Semaglutide ozempic wegovy

Deze tekst is gebaseerd op de bijsluiter van het beschreven medicijn en op andere, wetenschappelijke bronnen

If youre new or trying to get better at it here are trusted tips to avoid a semaglutide injection site reaction

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand name Ozempic) and chronic weight management (Wegovy)

For Ozempic: If fewer than 5 days have elapsed since your missed dose, take it as soon as you remember, then resume your regular weekly schedule

Recent studies suggest a potential link between GLP-1 receptor agonists and an increased risk of gallbladder disease